• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 264-278 of 645 results

1653 Exhibit: Orange Book Approved Drug Products with Therapeutic Equivalence...

Document IPR2017-00190, No. 1653-302 Exhibit - Orange Book Approved Drug Products with Therapeutic Equivalence Evaluations Search results for Efinaconazole (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

1578 Exhibit: Valeant Pharmaceuticals International, Inc Second Quarter 2016 Con...

Document IPR2017-00190, No. 1578-227 Exhibit - Valeant Pharmaceuticals International, Inc Second Quarter 2016 Conference Call Presentation (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

1568 Exhibit: Prescription Drug Pricing in the Private Sector a CBO Paper

Document IPR2017-00190, No. 1568-217 Exhibit - Prescription Drug Pricing in the Private Sector a CBO Paper (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

2071 Exhibit: Kaken Exhibit 2071

Document IPR2017-00190, No. 2071-117 Exhibit - Kaken Exhibit 2071 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

2010 Exhibit: Kaken Exhibit 2010

Document IPR2017-00190, No. 2010-56 Exhibit - Kaken Exhibit 2010 (P.T.A.B. Feb. 2, 2017)

cite Cite Document
Analyze

1019 Exhibit: van Hoogdalem, EJ et al, Eur J Pharm Sci 5 119 127 1997

Document IPR2017-00190, No. 1019-19 Exhibit - van Hoogdalem, EJ et al, Eur J Pharm Sci 5 119 127 1997 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

1026 Exhibit: Niewerth, M, Drugs 582283 296 1999

Document IPR2017-00190, No. 1026-26 Exhibit - Niewerth, M, Drugs 582283 296 1999 (P.T.A.B. Nov. 2, 2016)

cite Cite Document
Analyze

1591 Exhibit: Valeant Pharmaceuticals International, Inc Q3 2015 Financial Results...

Document IPR2017-00190, No. 1591-240 Exhibit - Valeant Pharmaceuticals International, Inc Q3 2015 Financial Results Presentation (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

2012 Exhibit: Kaken Exhibit 2012

Document IPR2017-00190, No. 2012-58 Exhibit - Kaken Exhibit 2012 (P.T.A.B. Feb. 2, 2017)

cite Cite Document
Analyze

1627 Exhibit: CVS Plans to Restrict $1,000 Toenail Fungus Drug Jublia

Document IPR2017-00190, No. 1627-276 Exhibit - CVS Plans to Restrict $1,000 Toenail Fungus Drug Jublia (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

1661 Exhibit: Kaken Exhibit 2100, Evidentiary Declaration of Edward Shupenus

Document IPR2017-00190, No. 1661-310 Exhibit - Kaken Exhibit 2100, Evidentiary Declaration of Edward Shupenus (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

1632 Exhibit: CVS Just Made Valeant¿¿¿s Day Even Worse

Document IPR2017-00190, No. 1632-281 Exhibit - CVS Just Made Valeant¿¿¿s Day Even Worse (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze

2059 Exhibit: Kaken Exhibit 2059

Document IPR2017-00190, No. 2059-106 Exhibit - Kaken Exhibit 2059 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

2040 Exhibit: Kaken Exhibit 2040

Document IPR2017-00190, No. 2040-87 Exhibit - Kaken Exhibit 2040 (P.T.A.B. Aug. 1, 2017)

cite Cite Document
Analyze

1649 Exhibit: Consolidated Financial Results for Fiscal 2016 Reference Data of Fina...

Document IPR2017-00190, No. 1649-298 Exhibit - Consolidated Financial Results for Fiscal 2016 Reference Data of Financial Statements Fiscal 2016 1st Quarter (P.T.A.B. Nov. 1, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 18 19 20 21 22 ... >>